The percentage of CD103+ DC was substantially increased in both tumour-draining LNs and tumours from Y27632-treated mice, compared with those from vehicle-treated mice (Fig. 4g and Supplementary Fig. 12). This evidence concerns the gene ITGAE and neoplasm.